The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Low-dose naltrexone shows promise for long COVID
New Zealand Doctor Rata Aotearoa
David Codyre
Wednesday 8 January 2025
Psychiatrist David Codyre reviews the growing evidence for low-dose naltrexone in the treatment of functional syndromes such as fibromyalgia, chronic fatigue and long COVID
Key points, In low doses (typically 3–4.5mg daily), naltrexone appears to modulate ...
Subscription required: Follow link i f you have, or want, a subscription to this medical website
Journal of Translational Medicine
2024 Jul 5;22(1):630.
Matthias Löhn & Klaus Josef Wirth
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia
Hiten Naik et al. Online issue publication May 13, 2024
Exciting breakthrough offers hope for Long COVID patients
Published May 7, 2024
Author Emma O'Connor - Griffith University
https://news.griffith.edu.au/2024/05/07/exciting-breakthrough-offers-hope-for-long-covid-patients/
Opioid Addiction Medication Could Bring Relief to Long COVID Patients
Naltrexone offers hope for alleviating various long COVID symptoms, including brain fog and muscle fatigue.
Published: May 9, 2024 Blake Forman
Technology Networks, Immunology & Microbiology
I’ve lost everything: Globetrotting DJ bedbound by long Covid says condition cost him career, friends and mobility
Staff Reporter10 May 2024
Addiction Medication Offers New Hope for Long COVID Patients
Featured in Neurology Neuroscience·May 7, 2024
New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
December 21, 2023
https://www.medscape.com/viewarticle/new-research-aims-unravel-both-me-cfs-and-long-covid-2023a1000w9b
Bethesda, MD — New research into the mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID is aimed at identifying potential approaches to treatment of the two overlapping illnesses.
Low-Dose Naltrexone Improves post-COVID-19 Condition Symptoms
Leonardo Tamariz, Elizabeth Bast, Nancy Klimas, Ana Palacio
Clin Ther, . 23rd Jan 2024:S0149-2918(24)00003-1. https://pubmed.ncbi.nlm.nih.gov/38267326/
Abstract
Purpose: Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic.
New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
Medscape Medical News > Conference News
December 21, 2023